Plan Termination

Plan termination refers to the process of permanently discontinuing an employer-sponsored 401(k) retirement savings plan. It occurs for various reasons, such as the company's financial restructuring, mergers, or a strategic shift in employee benefits. When a plan termination takes place, employees are typically given options for their vested funds, and the plan is effectively dissolved.

Explanation: Plan termination involves several essential steps, including notifying plan participants about the impending closure, ceasing any contributions from both employers and employees, and ensuring that all assets within the plan are appropriately distributed or rolled over to eligible accounts.

Examples:

  • Corporate Restructuring: In the case of a company facing financial challenges or bankruptcy, they might decide to terminate their 401(k) plan to cut costs and meet financial obligations. Employees would be informed about the termination and given options to withdraw their vested funds or roll them into individual retirement accounts (IRAs) or other eligible plans.

  • Mergers and Acquisitions: When two companies merge, they may choose to terminate one of the existing 401(k) plans to streamline their employee benefits. The employees from the terminated plan would then be integrated into the surviving company's retirement savings program, ensuring a smooth transition.

  • Benefit Plan Changes: An employer might decide to terminate an existing 401(k) plan if they opt to adopt a different retirement savings scheme, such as a defined benefit plan or switch to a new 401(k) provider with different plan features. In such cases, employees are given ample notice and guidance to manage their retirement savings effectively.

Plan termination is a significant event that requires careful handling to safeguard the interests of plan participants and ensure compliance with relevant legal regulations governing retirement plans.

Next Up

According to Mployer Insights’ 2026 analysis of 76,000+ employer benefit plans, disability insurance remains a major market differentiator, with only 41% of U.S. employers offering short-term disability (STD) and 38% offering long-term disability (LTD). While 60% salary replacement serves as the national standard across both benefit types, standard plan designs disproportionately expose higher earners due to median benefit caps of $1,602/week for STD and $8,273/month for LTD. Furthermore, alignment between STD benefit durations (median 26 weeks) and LTD elimination periods (68% at 90 days) remains a critical area for plan structure optimization.
Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.